Clinical Trial Update: Clinical Trial to Investigate the Efficacy and Safety of NuSepin® in COVID-19 Pneumonia Patients [Phase 2]

View source ↗

Summary

Phase 2 trial investigating the efficacy and safety of NuSepin® in COVID-19 pneumonia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Pneumonia

Drugs mentioned

• NuSepin®

Snippet

Sponsor: Shaperon | Conditions: COVID19 Pneumonia | Phase 2 | Status: COMPLETED